Position in JNJ
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$5,022,256
+$90,191 QoQ
Shares Held
19,775
-2.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.38%
of 13F equity value
Holder Rank
#1,613
of 4,676 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Concord Wealth Partners holds $18,338,750 across 12 Drug Manufacturers - General names. JNJ ranks #1 (27.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
19,775 | $5,022,256 | |
| 2 | LLY |
ELI LILLY & Co
|
3,673 | $4,405,506 | |
| 3 | AMGN |
Amgen Inc
|
11,144 | $4,035,465 | |
| 4 | ABBV |
AbbVie Inc.
|
7,796 | $1,961,785 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
20,943 | $1,206,735 | |
| 6 | PFE |
Pfizer Inc
|
47,796 | $1,150,927 | |
| 7 | MRK |
Merck & Co., Inc.
|
1,770 | $227,445 | |
| 8 | NVS |
Novartis AG
|
1,264 | $198,094 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,022,256 | 19,775 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $4,932,065 | 20,177 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $4,116,235 | 19,890 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $3,650,734 | 19,689 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $3,184,073 | 20,845 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $3,824,436 | 23,061 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $3,357,497 | 23,216 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $4,333,484 | 26,740 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $3,842,692 | 26,291 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $4,342,948 | 27,454 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $3,943,891 | 25,162 | Shares | Sole | 2024-04-30 | |
| 2023-09-30 | $3,275,578 | 21,031 | Shares | Sole | 2024-04-30 | |
| 2023-06-30 | $3,154,480 | 19,058 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,021,045 | 13,039 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $1,476,794 | 8,360 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $1,831,919 | 11,214 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,051,660 | 11,558 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $2,113,822 | 11,927 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $1,939,591 | 11,338 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $688,474 | 4,263 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $1,581,009 | 9,597 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $1,445,293 | 8,794 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $668,235 | 4,246 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||